Brief: Chimerix Awarded Barda Contract For Tembexa As Medical Countermeasure For Smallpox

Chimerix

29/08/2022 15:47

Aug 29 (Reuters) - Chimerix Inc:
    * CHIMERIX AWARDED BARDA CONTRACT FOR TEMBEXA AS MEDICAL
COUNTERMEASURE FOR SMALLPOX
    * CHIMERIX INC - INITIAL PROCUREMENT OF 319,000 TREATMENT
COURSES
FOR $115M WITH ADDITIONAL PROCUREMENTS AT BARDA'S DISCRETION
OVER 10 YEARS
    * CHIMERIX INC - EMERGENT BIOSOLUTIONS, INC. PAYMENT
INCREASES TO
$238M UPFRONT AND $136.5M IN POTENTIAL MILESTONES
    * CHIMERIX INC -  10-YEAR CONTRACT IS VALUED AT
APPROXIMATELY $551
MILLION IN TOTAL IF BARDA ELECTS TO EXERCISE ALL OPTIONS
    * CHIMERIX - CONTRACT SUPPORTS POST-MARKETING ACTIVITIES OF
ABOUT
$13 MILLION, FOR A TOTAL POTENTIAL CONTRACT VALUE OF UP TO $680
MILLION

Source text for Eikon:  ID:nGNX9ZFX42 
Further company coverage:  CMRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))